logo

A highly interdisciplinary and intersectoral training network for the development
of innovative antigen-specific immune therapies for autoimmune diseases

RESEARCH

Next generation of innovative antigen-specific immune therapies for autoimmune diseases

TOLERATE is a Doctoral Network (DN) funded by the European Union Horizon Europe Programme. TOLERATE aims at training Doctoral Candidates (DCs) to acquire the skills to develop different innovative strategies to treat autoimmune diseases, to identify the most promising strategies or a combination of strategies, to setup clinical trials and to develop a roadmap to bring a novel therapeutic agent to the market.

research-icon

RESEARCH

A highly innovative research programme focused on the orphan autoimmune disease iTTP

research-icon

TRAINING

Training next generation of highly skilled professionals with the expertise and skills to decrease the burden of autoimmune disease in Europe

research-icon

DCs PROJECTS

Providing a solid understanding on novel therapies for autoimmune diseases and the importance of long-term follow-up of patients

Building bridges between Industry and Academia

 

Both the presence of academia and industry provides a platform for in-depth preclinical studies and a realistic possibility for future commercialization of the novel therapies. Clinicians with expertise in setting-up and running clinical trials for novel drugs assure that developed novel therapies in TOLERATE will find their way to the clinic in the future.

CONSORTIUM

A multidisciplinary, intersectorial and international network that offers the best response to the scientific, economic and societal challenges linked to autoimmune diseases

BENEFICIARIES

Training next generation of highly skilled professionals with the expertise and skills to decrease the burden of autoimmune disease in Europe

ASSOCIATED PARTNERS

Providing a solid understanding on novel therapies for autoimmune diseases and the importance of long-term follow-up of patients

Managing long-term follow-up of patients and improve treatment timing

 
 

Developing novel therapies for autoimmune diseases goes close together with a thorough knowledge on the long-term consequences of living with an autoimmune disease.